GH NASDAQ
Guardant Health, Inc.
1W: +9.5%
1M: +0.4%
3M: +23.6%
YTD: +75.0%
1Y: +146.8%
3Y: +585.1%
5Y: +79.1%
$178.06
+4.81 (+2.78%)
Weekly Expected Move ±7.0%
$146
$157
$169
$181
$193
Credit Risk of going bust: lower than 59% of companies Debt: 6.6% of company value Bonds: $181.2M held by 51 funds → details ▾
Of US companies ranked in the middle of the pack, about 1 in 580 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $1.31 (down 99.3%), Guardant Health, Inc. would be worth roughly what it owes.
Total debt $1.70B against a stock market value of $23.89B.
Distance to default 6.14 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $751.5M (short-term plus half of long-term), stock volatility 56.8%; Altman Z'' -3.67. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.
If the stock fell to about $1.31 (down 99.3%), Guardant Health, Inc. would be worth roughly what it owes.
Total debt $1.70B against a stock market value of $23.89B.
Distance to default 6.14 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $751.5M (short-term plus half of long-term), stock volatility 56.8%; Altman Z'' -3.67. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
5 relationships5
As Filer
counterparties named
0
As Counterparty
mentioned by others
1
Rel. Types
2024-08-23
Earliest Filing
2025-11-07
Latest Filing
partner: 5
Counterparties (Filed by GH)
5 relationshipsCompanies named in GH's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Goldman Sachs & Co. LLC | GSCE | partner | Representative of underwriters for the Common Stock Offering | 2025-11-07 | View |
| Jefferies LLC | JEF | partner | Representative of underwriters for the Common Stock Offering | 2025-11-07 | View |
| U.S. Bank Trust Company, National Association | — | partner | Trustee for the Convertible Notes Offering | 2025-11-07 | View |
| U.S. Bank Trust Company, National Association | — | partner | Served as trustee for the New Notes Indenture. | 2025-02-14 | View |
| Jefferies LLC | JEF | partner | Sales agent for the Company's at-the-market offering program. | 2024-08-23 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-07-30 | Earnings Release; Exhibits | View | |
| 2026-06-18 | Shareholder Vote | View | |
| 2026-05-07 | Earnings Release; Exhibits | View | |
| 2026-04-27 | Officer/Director Change | View | |
| 2026-02-19 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2026-01-12 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View | |
| 2025-11-07 | Entry into Material Definitive Agreement; Creation of Direct Financial Obligation; Unregistered Sale | Agreement | View |
| 2025-10-29 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-09-24 | Regulation FD Disclosure | View | |
| 2025-09-15 | Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits | View | |
| 2025-07-30 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-06-20 | Submission of Matters to a Vote of Security Holders | View | |
| 2025-04-30 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-04-09 | Entry into Material Definitive Agreement; Creation of Direct Financial Obligation; Financial Stateme | Agreement | View |
| 2025-02-20 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-02-14 | Entry into Material Definitive Agreement; Creation of Direct Financial Obligation; Unregistered Sale | Agreement | View |
| 2025-02-07 | Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Financial Stateme | Agreement | View |
| 2025-01-13 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View | |
| 2024-11-06 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2024-10-24 | Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR